−150 KRW
−2.84 B KRW
6.50 B KRW
7.56 M
About ANTEROGEN CO., LTD.
Sector
Industry
Headquarters
Seoul
Website
Founded
2000
ISIN
KR7065660003
FIGI
BBG00BDRGMN0
Anterogen Co., Ltd. engages in the development and sale of stem cell therapy treatments. Its products include Cupistem and Remodullin injection, Queencell, and stem cell conditioned media. It also offers stem cell banking and analysis services. The company was founded on March 16, 2000 and is headquartered in Seoul, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 065660 is 15,700 KRW — it has increased by 1.02% in the past 24 hours. Watch ANTEROGEN CO., LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange ANTEROGEN CO., LTD. stocks are traded under the ticker 065660.
065660 stock has fallen by −12.36% compared to the previous week, the month change is a 1.22% rise, over the last year ANTEROGEN CO., LTD. has showed a 2.48% increase.
065660 reached its all-time high on Apr 16, 2018 with the price of 238,000 KRW, and its all-time low was 12,300 KRW and was reached on Oct 18, 2023. View more price dynamics on 065660 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
065660 stock is 3.00% volatile and has beta coefficient of 1.13. Track ANTEROGEN CO., LTD. stock price on the chart and check out the list of the most volatile stocks — is ANTEROGEN CO., LTD. there?
Today ANTEROGEN CO., LTD. has the market capitalization of 152.30 B, it has increased by 2.58% over the last week.
Yes, you can track ANTEROGEN CO., LTD. financials in yearly and quarterly reports right on TradingView.
065660 net income for the last quarter is −162.43 M KRW, while the quarter before that showed −517.96 M KRW of net income which accounts for 68.64% change. Track more ANTEROGEN CO., LTD. financial stats to get the full picture.
No, 065660 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 23, 2024, the company has 37.00 employees. See our rating of the largest employees — is ANTEROGEN CO., LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ANTEROGEN CO., LTD. EBITDA is −2.43 B KRW, and current EBITDA margin is −65.02%. See more stats in ANTEROGEN CO., LTD. financial statements.
Like other stocks, 065660 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ANTEROGEN CO., LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ANTEROGEN CO., LTD. technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ANTEROGEN CO., LTD. stock shows the sell signal. See more of ANTEROGEN CO., LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.